Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry.

导出 LinkOut

翻译打印收藏纠错

作者： Yunnan,Zhang ^[1] ; Wenxing,Peng ^[2] ; Xiujin,Shi ^[1] ; Jialun,Han ^[1] ; Yifan,Wang ^[1] ; Zhenwei,Fang ^[2] ; Yang,Lin ^[1]

作者单位： Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. ^[1] School of Pharmaceutical Sciences, Capital Medical University, Beijing, China. ^[2]

关键词 acute coronary syndrome antiplatelet therapy clopidogrel older patients ticagrelor

DOI 10.3389/fcvm.2022.859962

PMID 35369358

发布时间 2023-11-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Frontiers in cardiovascular medicine

2022年9卷

859962页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry.

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry.

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

检索历史清除